Myasthenia gravis (MG)

Specialty: Neurology


IVIG is recommended as first-line treatment in moderate-severe MG or in myasthenic crisis.

IVIG in combinations with immunosuppressive therapy can be considered in refractory cases.


Initial dose: 2 g/kg divided over 2 to 5 days.

If additional therapy is required, the dose should be adjusted depending upon response and titrated to the minimum effective dose.